APOE and Alzheimer disease: By contrast, a standard AD GRS(based on variants associated with clinically diagnosed AD dementia) wasassociated with these amyloid outcomes in each tested sample(p < 0.005), highlighting the specificity of thenon-APOE amyloid GRS applying to theAPOE ɛ3/ɛ3 setting.